GlobeNewswire
-
Press Release: Sanofi’s next-generation rabies vaccine, VaxRabeo, approved in the EU for all ages
19/11/2026 -
Communiqué de presse : VaxRabeo, le vaccin contre la rage de nouvelle génération de Sanofi, approuvé dans l’UE pour tous les âges
19/11/2026 -
Novartis projects +5% cc¹ sales CAGR through 2031 and sustained mid-single-digit growth over the long term
19/11/2026 -
Fangzhou and Baiyunshan Pharmaceutical Launch AI-Powered Chronic Disease Management Initiative
19/11/2026 -
SELLAS Life Sciences Announces Pricing of $150.0 Million Underwritten Public Offering
19/11/2026 -
Immutep Reports Encouraging Disease-Free Survival from EFTISARC-NEO Phase II Trial in Soft Tissue Sarcoma
19/11/2026 -
HUTCHMED Highlights HMPL-A830 Pre-Clinical Data Presented at the 38th EORTC-NCI-AACR International Conference on Molecular Targets and Cancer Therapeutics
19/11/2026 -
Rosedil Introduces Rosedil Capsules, a Biotin, Zinc and Horsetail Dietary Supplement for Hair Wellness Routines
19/11/2026 -
Livsayis™ (cemdisiran) Approved by the FDA as First and Only siRNA Therapy in Generalized Myasthenia Gravis and Only Treatment with Four-Times-a-Year Subcutaneous Dosing
19/11/2026 -
Pyxis Oncology to Host Live Webcast on Updated MICVO Phase 1 Monotherapy Data Demonstrating Durable Response in 2L+ R/M HNSCC Following Late-Breaking Oral Presentation at EORTC-NCI-AACR Symposium
19/11/2026 -
Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
18/11/2026 -
Press Release: Sanofi’s Infilbray approved in the US as the first medicine to treat neurological manifestations of Type 3 Gaucher disease
18/11/2026 -
Communiqué de presse : Infilbray, de Sanofi, approuvé aux États-Unis comme le premier médicament indiqué dans le traitement des manifestations neurologiques de la maladie de Gaucher de type 3
18/11/2026 -
Teva Announces R&D Leadership Transition; Eric Hughes to Depart the Company
18/11/2026 -
Palvella Therapeutics to Host Webcast to Introduce New QTORIN™ Program
18/11/2026 -
MEDIROM Announces Receipt of Nasdaq Delisting Notice, Filing of Annual Report and Submission of Hearing Request
18/11/2026 -
His Choice Health Announces No Needle No Scalpel Vasectomy Clinic In Greenville, SC Opening January 7, 2027
18/11/2026 -
Onco360® Has Been Selected as a National Pharmacy Partner for PIMJETMI® (pimicotinib)
18/11/2026 -
Cytek Biosciences to Participate in Upcoming Investor Conferences
18/11/2026
Pages